Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Piperidine, 1-(3-chloropropyl)- → 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-4-(3-piperidin-1-yl-propyl)-[1,4]diazepan-5-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Piperidine, 1-(3-chloropropyl)- | HCID 79625 | — |
| 반응물 | 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-[1,4]diazepan-5-one | HCID 62044921 | — |
| 생성물 | 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-4-(3-piperidin-1-yl-propyl)-[1,4]diazepan-5-one | HCID 68431984 | — |
반응 단계
In analogy to the procedure described in intermediate 4A, 1-[(E)-3-(3,4-dichloro-phenyl)-acryloyl]-[1,4]diazepan-5-one (intermediate 1A) and 1-(3-chloro-propyl)-piperidine gave the title compound as light yellow solid. MS: 438.1 (MH+, 2Cl).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07632829B2 |
| 출처 데이터셋 | uspto-grants-2009_12 |
| ORD ID | ord-dffcd76c2a09470dad9f779a88f90324 |
| 출처 메모 | uspto-grants-2009_12 |